Establishment and Validation of an Orthotopic Metastatic Mouse Model of Colorectal Cancer

por Rajput, Ashwani, Agarwal, Ekta, Leiphrakpam, Premila, Brattain, Michael G., Chowdhury, Sanjib
Publicado 2013

Ron Knockdown and Ron Monoclonal Antibody IMC-RON8 Sensitize Pancreatic Cancer to Histone Deacetylase Inhibitors (HDACi)

por Zou, Yi, Howell, Gillian M., Humphrey, Lisa E., Wang, Jing, Brattain, Michael G.
Publicado 2013

Intra-Tumoral Heterogeneity in Metastatic Potential and Survival Signaling between Iso-Clonal HCT116 and HCT116b Human Colon Carcinoma Cell Lines

por Chowdhury, Sanjib, Ongchin, Melanie, Sharratt, Elizabeth, Dominguez, Ivan, Wang, Jing, Brattain, Michael G., Rajput, Ashwani
Publicado 2013

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer

por LEIPHRAKPAM, PREMILA D., AGARWAL, EKTA, MATHIESEN, MICHELLE, HAFERBIER, KATIE L., BRATTAIN, MICHAEL G., CHOWDHURY, SANJIB
Publicado 2014

Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer

por Agarwal, Ekta, Chaudhuri, Anathbandhu, Leiphrakpam, Premila D, Haferbier, Katie L, Brattain, Michael G, Chowdhury, Sanjib
Publicado 2014

Differential PKA activation and AKAP association determines cell fate in cancer cells

por Hedrick, Erik D, Agarwal, Ekta, Leiphrakpam, Premila D, Haferbier, Katie L, Brattain, Michael G, Chowdhury, Sanjib
Publicado 2013

TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells

por Bailey, Katie L., Agarwal, Ekta, Chowdhury, Sanjib, Luo, Jiangtao, Brattain, Michael G., Black, Jennifer D., Wang, Jing
Publicado 2017

Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells

por Simms, Neka A K, Rajput, Ashwani, Sharratt, Elizabeth A, Ongchin, Melanie, Teggart, Carol A, Wang, Jing, Brattain, Michael G
Publicado 2012

Identification of a Novel TGFβ/PKA Signaling Transduceome in Mediating Control of Cell Survival and Metastasis in Colon Cancer

por Chowdhury, Sanjib, Howell, Gillian M., Rajput, Ashwani, Teggart, Carol A., Brattain, Lisa E., Weber, Hannah R., Chowdhury, Aparajita, Brattain, Michael G.
Publicado 2011

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy

por Laschanzky, Richard S., Humphrey, Lisa E., Ma, Jihyun, Smith, Lynette M., Enke, Thomas J., Shukla, Surendra K., Dasgupta, Aneesha, Singh, Pankaj K., Howell, Gillian M., Brattain, Michael G., Ly, Quan P., Black, Adrian R., Black, Jennifer D.
Publicado 2019

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

por Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Publicado 2017

Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

por Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Publicado 2020